GL1X · GenesisL1 explorer

Research workbench

AlphaFold monomer V2.0 prediction for NAD-dependent protein deacylase SIR2 (A0R2N3)

Analyse AlphaFold monomer V2.0 prediction for NAD-dependent protein deacylase SIR2… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

Accession
A0R2N3
Type
protein
Length
240 residues
Chains
1
Collection
MolNFT v1 / AlphaFold
Contract
0xBf7491af3407816DFa88a5EA4c82e8A2B1D721eD
Owner
0xccb8A171172ee5a65301D5F34Eef7EA7D46093B4
Molecule
NAD-dependent protein deacylase SIR2
UniProt
A0R2N3
Pockets
1 · best druggability 0.79

Structure

1 distinct chain · 36% helix, 19% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ANAD-dependent protein deacylase SIR2protein24036% helix, 19% strandA0R2N3

Pockets

1 pocket found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
14070.790.8856empty

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.